Evaluation of the NaviFUS System in Drug Resistant Epilepsy | MicrobiomeTrials← Back to trialsNCT05947656
Evaluation of the NaviFUS System in Drug Resistant Epilepsy
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2023-10-02Est. Completion: 2027-06-01
Enrollment target: 18 participants Locations- The Alfred, Melbourne, Victoria, Australia
Other microbiome trials you might be interested in
EpilepsyEpilepsy, Temporal LobePartial Epilepsy
Background:
\- Drug resistant epilepsy is the term used to describe epilepsy that cannot be controlled by medication. M…
Bethesda, United States
Epilepsy
Background:
\- Epilepsy is a seizure disorder. Sometimes it is treated with surgery. During surgery, electrodes are pla…
Bethesda, United StatesCompleted Jan 1, 2027